Eisai To Double U.S. Sales Staff To Sell Anti-Obesity Drug Belviq
This article was originally published in PharmAsia News
Executive Summary
Eisai, U.S. marketer of the Arena Pharmaceuticals anti-obesity drug Belviq (lorcaserin), plans to double its sales representatives staff to 400 by December.